CereCRIBAlternative Names: ACTID
Latest Information Update: 13 Dec 2016
At a glance
- Originator StemCells
- Mechanism of Action Adrenergic receptor agonists; Opioid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 28 Nov 2016 StemCells has been acquired by Microbot Medical
- 24 May 2000 Discontinued-II for Pain in Switzerland (Intrathecal)
- 24 May 2000 Discontinued-II for Pain in USA (Intrathecal)